Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Findings from the first prospective validation trial for biomarker presented at ASTRO 2025
September 29, 2025
Findings from the first prospective validation trial for biomarker presented at ASTRO 2025